Dr. Agarwal's Health Care Limited has filed prior intimation with stock exchanges regarding a proposed inter-se share transfer within its promoter group, scheduled for March 13, 2026. The transaction involves the transfer of 14,41,568 shares between immediate relatives within the promoter family.

Transaction Details

The proposed share transfer will see Dr. Athiya Agarwal acquire shares from Dr. Anosh Agarwal through a gift arrangement between immediate relatives. The transaction parameters are outlined below:

Shareholding Impact

The inter-se transfer will result in changes to individual shareholdings within the promoter group while maintaining the overall promoter group stake. The shareholding pattern before and after the transaction shows:

Regulatory Compliance

The transaction is being conducted under Regulation 10(1)(a)(i) of SEBI SAST Regulations, 2011, which provides exemption for inter-se transfers among immediate relatives. Key compliance aspects include:

• Prior intimation filed under Regulation 10(5) of SEBI SAST Regulations
• Transfer qualifies for open offer exemption as inter-se transfer between immediate relatives
• No change in total promoter group shareholding
• Declaration of compliance with applicable disclosure requirements

Strategic Rationale

According to the filing, the proposed acquisition represents a private family arrangement among immediate relatives aimed at streamlining the family's assets and business interests. The transaction involves no monetary consideration as it is structured as a gift between family members.

The company has submitted the required declarations confirming compliance with all conditions specified under regulation 10(1)(a) regarding exemptions and applicable disclosure requirements under Chapter V of the Takeover Regulations, 2011.

Dr. Agarwal's Health Care has completed the formal regulatory disclosure process for the inter-se transfer of shares between promoter group members. Dr. Anosh Agarwal filed the mandatory disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 on March 6, 2026, following the transfer of 21,15,180 shares to Dr. Athiya Agarwal.

Transaction Overview

The share transfer was executed on March 4, 2026, as a gift transaction between immediate relatives within the promoter group. The acquisition represents 0.67% of the company's total share capital and was completed under SEBI's exemption provisions for inter-se transfers among promoters.

Shareholding Changes

The formal disclosure reveals the complete shareholding pattern changes resulting from the transaction. Dr. Anosh Agarwal's stake decreased from 5.36% to 4.69% of the total share capital following the transfer.

Regulatory Compliance

The company has fulfilled all mandatory disclosure requirements under SEBI regulations. The formal disclosure under Regulation 29(2) was submitted to BSE Limited and National Stock Exchange of India Limited on March 6, 2026. The transaction maintains compliance as it involves immediate relatives within the promoter group, ensuring no change in the overall promoter group shareholding.

The company's equity share capital remains unchanged at 31,68,07,506 equity shares of Re. 1/- each, aggregating to Rs. 31,68,07,506. The shares continue to be listed on both BSE Limited and National Stock Exchange of India Limited.